Strados Labs logo
  • For Clinicians
  • For Researchers
  • Media & Events
  • Support
  • About
  • For Clinicians
  • For Researchers
  • Media & Events
  • Support
  • About
Contact Us
Strados Labs Receives FDA 510(k) Clearance for Home Use of its Smart Sensor Platform for Respiratory Health, RESP®

Strados Labs Receives FDA 510(k) Clearance for Home Use of its Smart Sensor Platform for Respiratory Health, RESP®

by Will Oliason | May 3, 2022 | Press Releases

Philadelphia, PA May 3, 2022 — Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and proprietary algorithms to provide early detection and predictions of worsening respiratory diseases, today announced it has received...
Medtech Company, Strados Labs, Awarded National Science Foundation SBIR Phase II Grant

Medtech Company, Strados Labs, Awarded National Science Foundation SBIR Phase II Grant

by Will Oliason | Mar 10, 2022 | Press Releases

Funding will help Strados advance the power of its smart sensors to provide early detection and predictions of infectious respiratory diseases Philadelphia, PA, March 10, 2020 — Strados Labs, a medical technology company harnessing the power of smart sensors, machine...
Strados Labs, Growing Medtech Company, Raises $4.5M in Pre-series A Funding Round

Strados Labs, Growing Medtech Company, Raises $4.5M in Pre-series A Funding Round

by Will Oliason | Jan 4, 2022 | Press Releases

Funding to fuel next key milestones as company continues to target asthma, COPD and infectious respiratory diseases in 2022 Philadelphia, PA January 5, 2022 — Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and...
Procter & Gamble Health Care Veteran, Steve Bishop, Joins Strados Labs Board of Directors

Procter & Gamble Health Care Veteran, Steve Bishop, Joins Strados Labs Board of Directors

by Will Oliason | Dec 16, 2021 | Press Releases

Strados Labs harnesses the power of smart sensors and machine learning to aid in early detection and predictions of worsening respiratory diseases for enhanced patient care   Philadelphia, PA, December 16, 2021 – Strados Labs, a medical technology company harnessing...
Strados Labs Granted CE Mark for its RESP™ Smart Sensor Platform

Strados Labs Granted CE Mark for its RESP™ Smart Sensor Platform

by Juliette Bogus | Nov 18, 2021 | Press Releases

CE Mark expands the company’s reach to support customers on a global scale Philadelphia, PA, November 18, 2021 – Strados Labs, a medical technology company harnessing the power of smart sensors to aid in early detection and predictions of worsening diseases for...
Strados Labs receives FDA 510(k) clearance for its wireless lung sound measurement platform, RESP™

Strados Labs receives FDA 510(k) clearance for its wireless lung sound measurement platform, RESP™

by Nick Delmonico | Dec 22, 2020 | Press Releases

Philadelphia, PA December 22, 2020 — Strados Labs, a health technology developer of remote respiratory devices and software, today announced it has received FDA Class II 510(k) clearance for its first product, RESP™, a system for measuring, recording and analyzing...
« Older Entries

Recent Posts

  • Strados Labs Receives FDA 510(k) Clearance for Home Use of its Smart Sensor Platform for Respiratory Health, RESP®
  • Medtech Company, Strados Labs, Awarded National Science Foundation SBIR Phase II Grant
  • Strados Labs, Growing Medtech Company, Raises $4.5M in Pre-series A Funding Round
  • Procter & Gamble Health Care Veteran, Steve Bishop, Joins Strados Labs Board of Directors
  • Strados Labs Granted CE Mark for its RESP™ Smart Sensor Platform

Recent Comments

    Strados

    Headquarters
    Philadelphia, PA

    Research & Development
    Atlanta, GA

    About Strados

    Support

    Media & Events

    Technical Specs and FAQs

    Clinical Evidence

    Careers

    info@stradoslabs.com
    1-888-STRADOS

    • Follow
    • Follow
    • Follow

    © 2022 Strados Labs®  |  Privacy Policy  |   Cookie Policy